Fresenius | FRE - Cost Of Sales



Fresenius reported EUR4.12B in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Akzo Nobel EUR 1.59B 23M Jun/2025
Alcon AG USD 1.21B 118M Jun/2025
AstraZeneca USD 2.47B 232M Jun/2025
BASF EUR 11.59B 957M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Beiersdorf EUR 2.11B 130M Jun/2025
DaVita Healthcare Partners USD 2.26B 21.88M Jun/2025
Demant DKK 2.71B 46M Jun/2025
E.ON EUR 11.04B 8.71B Jun/2025
Essilor EUR 5.31B 2.79B Jun/2025
Fresenius EUR 4.12B 117M Jun/2025
Fresenius Medical Care EUR 3.58B 120M Jun/2025
Getinge SEK 6.02B 1.7B Dec/2024
Givaudan CHF 1.05B 936.5M Jun/2024
GlaxoSmithKline GBP 2.16B 241M Jun/2025
GN Store Nord DKK 1.93B 136M Jun/2025
GRIFOLS EUR 1.15B 56.19M Jun/2025
Hikma Pharmaceutical USD 895M 82M Dec/2024
Lonza CHF 2.47B 532M Dec/2024
Merck EUR 2.23B 93M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Philips EUR 2.33B 79M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
RWE EUR 3.42B 1.42B Jun/2025
Sanofi EUR 2.99B 103M Jun/2025
Smith & Nephew USD 870M 41M Jun/2025